Shariah compliance overview
HalalMyriad Genetics, Inc. (MYGN) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).
About Myriad Genetics, Inc.
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomics.
Myriad Genetics, Inc. (MYGN) operates in the Healthcare sector, in the Medical - Diagnostics & Research industry.
Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 0.22% (limit 5%), interest-bearing debt is 10.06% (limit 30%) and interest-bearing securities and assets are 12.55% (limit 30%).
If you hold MYGN, give 0.22% of the dividends you receive to charity to purify the non-compliant share of its income.
- Business Activity
- 0.22%Limit 5%Pass
- Interest-bearing debt
- 10.06%Limit 30%Pass
- Interest-bearing securities and assets
- 12.55%Limit 30%Pass
- Dividend purification
- 0.22%Share of dividends to give to charityPurification calculator
Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.
Please login to access this content
Please login to access this content
Please login to access this content
Company Profile
Please login to access this content
Frequently asked questions
Quick answers about Myriad Genetics, Inc. (MYGN). Current Akinda screening label: Halal.
